Or that’s the message Aviva gave when it unveiled a healthy regulatory surplus. But, as Angelique Ruzicka discovers, some commentators believe the company may still have to raise more capital.
Take out a print and online or online only subscription and you will get immediate access to:
Get access now subscribe today
Alternatively, REGISTER to receive free email alerts